Skip to main content
. 2022 Dec 8;92(4):680–694. doi: 10.1227/neu.0000000000002275

FIGURE 1.

FIGURE 1.

Peer-reviewed publications in psychedelic science from 1990 through June 2022: The four graphs show over the last 3 decades an initial slow then rapid rise in articles focused on clinical applications of all psychedelics, MDMA, psilocybin, and LSD. Publications are shaded to distinguish between CT results or MA and R (Methodology: PubMed was searched using the terms: psychedelic, clinical trial, LSD, 3,4-MDMA, and psilocybin for both human and animal investigations.). CT, clinical trial; LSD, lysergic acid diethylamide; MA, meta-analyses; MDMA, 3,4-methylenedioxymethamphetamine; R, reviews.